UMSL partnering with API Innovation Center to help secure and strengthen the supply chain for essential pharmaceuticals in U.S.
APIIC and its partners have been awarded $14 million in federal funding to lead the development and domestic production of three critical APIs used in the treatment of asthma, diabetes and anxiety disorders.